Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
03/24

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced on Mar, 24 2026 that China Galaxy Securities Co., Ltd., its placement agent for the A-share placement initiated in Jul, 2015, has replaced one of its supervisory representatives.

Due to a change in work arrangements, Mr. Wang Jianlong will no longer serve in the role. Galaxy Securities has appointed Ms. Wang Han to assume the continuous supervision duties alongside existing representative Ms. Kang Yuan.

Although the formal supervision period for the placement has concluded, some proceeds from the fundraising remain unutilised, and the placement agent will continue to monitor the deposit and use of these funds.

The board expressed gratitude to Mr. Wang Jianlong for his contributions and confirmed that Ms. Wang Han, a sponsor representative with six years of investment-banking experience, will take over immediately.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10